Compugen | CGEN - Interest Expense On Debt


Compugen reported $954K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
Cara Therapeutics 43.75M 4.8M Jun/2025
Compugen USD 954K 116K Sep/2025
Immunic 400K 400K Dec/2024
Infinity Pharmaceuticals USD 45K 0 Jun/2023
Minerva Neurosciences USD 2.31M 60K Jun/2024
RedHill Biopharma USD 89.8K 31.69M Jun/2024
TherapeuticsMD USD 20K 25K Sep/2023